Xilio Therapeutics, Inc.
XLO$50M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaWALTHAM64 employees
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Mar 30, 2026
2dMarket Overview
Stock performance and key metrics
XLO News
Catalyst Timeline
2 upcoming, 1 past
Phase 2Next
vilastobart (XTX101) Phase 2 Results Expected
Mar 30, 2026Estimatedvilastobart (XTX101)136
Primary completion for vilastobart (XTX101) trial (NCT04896697) in Advanced Solid Tumor
Source1 more catalyst beyond 14 days
Start a 48h free trial to see all upcoming catalysts
Drug Pipeline
XTX202
Advanced Solid Tumor
vilastobart (XTX101)
Advanced Solid Tumor
XTX301
Advanced Solid Tumor
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
XTX202 | Phase 2 | Advanced Solid Tumor | - | - |
vilastobart (XTX101) | Phase 2 | Advanced Solid Tumor | - | - |
XTX301 | Phase 2 | Advanced Solid Tumor | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply